CULLINAN THERAPEUTICS
16.51
07-November-24 11:25:31
15 minutes delayed
Stocks
+0.03
+0.18%
Today's range
16.35 - 17.19
ISIN
N/A
Source
NASDAQ
-
Cullinan Oncology to Present at the 42nd Annual J.P. Morgan Healthcare Conference
18 Dec 2023 15:53:03 By Nasdaq GlobeNewswire
-
14 Dec 2023 15:30:00 By Nasdaq GlobeNewswire
-
Cullinan Oncology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
08 Nov 2023 06:00:03 By Nasdaq GlobeNewswire
-
03 Nov 2023 11:01:00 By Nasdaq GlobeNewswire
-
Cullinan Oncology to Participate in Upcoming Investor Conferences
30 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
Cullinan Oncology to Participate in Upcoming Investor Conferences
06 Sep 2023 07:00:00 By Nasdaq GlobeNewswire
-
Cullinan Oncology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
10 Aug 2023 06:00:01 By Nasdaq GlobeNewswire
-
09 Aug 2023 06:00:51 By Nasdaq GlobeNewswire
-
Cullinan Oncology to Participate in Upcoming Investor Conferences
31 Jul 2023 07:00:01 By Nasdaq GlobeNewswire
-
25 May 2023 16:00:26 By Nasdaq GlobeNewswire
-
Cullinan Oncology Provides Corporate Update and Reports First Quarter 2023 Financial Results
11 May 2023 15:01:01 By Nasdaq GlobeNewswire
-
26 Apr 2023 09:08:32 By Nasdaq GlobeNewswire
-
Cullinan Oncology to Participate in Stifel’s 2023 Targeted Oncology Days
20 Apr 2023 06:00:00 By Nasdaq GlobeNewswire
-
27 Mar 2023 06:00:06 By Nasdaq GlobeNewswire
-
14 Mar 2023 15:35:18 By Nasdaq GlobeNewswire
-
09 Mar 2023 06:00:01 By Nasdaq GlobeNewswire
-
Cullinan Oncology to Participate in Cowen’s 43rd Annual Health Care Conference
27 Feb 2023 07:00:02 By Nasdaq GlobeNewswire
-
13 Feb 2023 18:00:00 By Nasdaq GlobeNewswire
-
02 Feb 2023 15:01:00 By Nasdaq GlobeNewswire
-
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Feb 2023 15:41:55 By Nasdaq GlobeNewswire